Skip to Main Content
Table 1—

Clinical and biochemical data of metabolic syndrome and control subjects

Metabolic syndrome subjectsControl subjectsP*
n 269 210  
Age (years) 58.7 (57.5–59.9) 57.4 (55.6–59.2) 0.219 
Male sex (%) 79.6 65.2 <0.001 
BMI (kg/m2) 28.5 (28.1–28.9) 24.5 (24.0–24.9) <0.001 
Glucose (mmol/l) 6.30 (6.11–6.50) 5.31 (5.22–5.40) <0.001 
Triglycerides (mmol/l) 2.27 (2.15–2.39) 1.27 (1.21–1.34) <0.001 
LDL cholesterol (mmol/l) 3.70 (3.57–3.83) 3.45 (3.33–3.57) 0.007 
HDL cholesterol (mmol/l) 1.02 (0.99–1.05) 1.48 (1.43–1.53) <0.001 
Hypertension (%) 73.3 22.0 <0.001 
Insulin (μU/ml) 14.77 (13.81–15.80) 12.32 (11.44–13.28) <0.001 
HOMA§ 4.14 (3.88–4.58) 2.92 (2.69–3.16) <0.001 
hs-CRP (mg/l) 2.97 (2.61–3.39) 1.65 (1.40–1.95) <0.001 
Ferritin (μg/l) 124.0 (111.2–138.2) 82.7 (72.6–94.3) <0.001 
C282Y heterozygotes (%) 3.7 6.5 0.178 
Prevalence of body iron excess (%) 14.5 8.1 0.03 
Metabolic syndrome subjectsControl subjectsP*
n 269 210  
Age (years) 58.7 (57.5–59.9) 57.4 (55.6–59.2) 0.219 
Male sex (%) 79.6 65.2 <0.001 
BMI (kg/m2) 28.5 (28.1–28.9) 24.5 (24.0–24.9) <0.001 
Glucose (mmol/l) 6.30 (6.11–6.50) 5.31 (5.22–5.40) <0.001 
Triglycerides (mmol/l) 2.27 (2.15–2.39) 1.27 (1.21–1.34) <0.001 
LDL cholesterol (mmol/l) 3.70 (3.57–3.83) 3.45 (3.33–3.57) 0.007 
HDL cholesterol (mmol/l) 1.02 (0.99–1.05) 1.48 (1.43–1.53) <0.001 
Hypertension (%) 73.3 22.0 <0.001 
Insulin (μU/ml) 14.77 (13.81–15.80) 12.32 (11.44–13.28) <0.001 
HOMA§ 4.14 (3.88–4.58) 2.92 (2.69–3.16) <0.001 
hs-CRP (mg/l) 2.97 (2.61–3.39) 1.65 (1.40–1.95) <0.001 
Ferritin (μg/l) 124.0 (111.2–138.2) 82.7 (72.6–94.3) <0.001 
C282Y heterozygotes (%) 3.7 6.5 0.178 
Prevalence of body iron excess (%) 14.5 8.1 0.03 
*

Quantitative data were analyzed by Student’s unpaired t test; qualitative variables by χ2.

Data are means (95% CI).

Skewed variables, for which data are geometric means (95% CI).

§

Homeostasis model assessment (HOMA) (30) was calculated as fasting insulin (μU/ml) × fasting glucose (mmol/l)/22.5.

Odds ratio 1.92 (95% CI 1.05–3.5).

Close Modal

or Create an Account

Close Modal
Close Modal